has been cited by the following article(s):
|
[1]
|
Single-Dose Lentiviral Mediated Gene Therapy Recovers CFTR Function in Cystic Fibrosis Knockout Rats
Frontiers in Pharmacology,
2021
DOI:10.3389/fphar.2021.682299
|
|
|
|
|
[2]
|
Insights into the variability of nasal potential difference, a biomarker of CFTR activity
Journal of Cystic Fibrosis,
2019
DOI:10.1016/j.jcf.2019.09.015
|
|
|
|
|
[3]
|
Analysis of nasal potential in murine cystic fibrosis models
The International Journal of Biochemistry & Cell Biology,
2016
DOI:10.1016/j.biocel.2016.10.001
|
|
|
|
|
[4]
|
Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?
Journal of Cystic Fibrosis,
2015
DOI:10.1016/j.jcf.2014.09.006
|
|
|
|
|
[5]
|
Nasal potential difference measurements in diagnosis of cystic fibrosis: An international survey
Journal of Cystic Fibrosis,
2014
DOI:10.1016/j.jcf.2013.08.006
|
|
|
|
|
[6]
|
Correction of Chloride Transport and Mislocalization of CFTR Protein by Vardenafil in the Gastrointestinal Tract of Cystic Fibrosis Mice
PLoS ONE,
2013
DOI:10.1371/journal.pone.0077314
|
|
|
|
|
[7]
|
Miglustat effects on the basal nasal potential differences in cystic fibrosis
Journal of Cystic Fibrosis,
2013
DOI:10.1016/j.jcf.2012.06.004
|
|
|
|
|
[8]
|
Cystic fibrosis: Insight into CFTR pathophysiology and pharmacotherapy
Clinical Biochemistry,
2012
DOI:10.1016/j.clinbiochem.2012.05.034
|
|
|
|